GOLDSTEIN DOV A MD - 03 Jan 2023 Form 4 Insider Report for Coya Therapeutics, Inc. (COYA)

Role: Director
Signature: /s/ David Snyder, Attorney-in-Fact
Issuer symbol: COYA
Transactions as of: 03 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 04 Jan 2023, 07:30:17 UTC
Previous filing: 28 Dec 2022
Next filing: 26 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	COYA	Common Stock, par value $0.0001 per share	Purchase		+10,000			10,000	03 Jan 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	COYA	Warrant to Purchase Common Stock	Purchase		+5,000			5,000	03 Jan 2023	Common Stock, par value $0.0001 per share	5,000	$7.50	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reporting Person purchased 10,000 shares of Common Stock and an accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant.